Date: Thursday 30 Dec 2010
Speciality pharmaceutical company ProStrakan saw its share price move into three figures Thursday as it announced it has received US regulatory approval for its FORTESTA drug.
No recent information was found.
| Endo to Buy Apax’s Qualitest for $1.2 Billion | 29-Sep-2010 | New York Times |
| Stocks reverse early slide, end with slight gains | 29-Sep-2010 | Wall Street Journal |
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 33.57 |
| Change Today | $ 0.29 |
| % Change | 0.87 % |
| 52 Week High | $41.73 |
| 52 Week Low | $26.51 |
| Volume | 499,913 |
| Shares Issued | 117.19m |
| Market Cap | $3,934.06m |
| Beta | 0.94 |
| RiskGrade | 117 |
| Strong Buy | 16 |
| Buy | 1 |
| Neutral | 9 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 26 |

| Time | Volume / Share Price |
| 16:00 | 1,200 @ $33.57 |
| 16:00 | 47,802 @ $33.57 |
| 15:59 | 106 @ $33.56 |
| 15:59 | 100 @ $33.56 |
| 15:59 | 161 @ $33.56 |
You are here: research